FindTrial
Sign In

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00593190
Enrollment
8
Registered
2008-01-14
Start date
2008-01-31
Completion date
2010-05-31
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrops in Keratoconus

Brief summary

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

Interventions

DRUGGas SF6 (Sulfur Hexafluoride)

ONCE

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hydrops

Exclusion criteria

* Age \< 18 years old

Design outcomes

Primary

MeasureTime frame
Hydrops resulotionweeks

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026